At a Glance
Women’s Health (osteoporosis)
NDA has been submitted, awaiting final FDA approval.
Applications In Development:
VIVIANT® (bazedoxifene) is a synthetic drug that was specifically designed to reduce the risk of osteoporotic fractures while at the same time protecting breast and uterine tissue.